These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 1313894

  • 1. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
    Brooks L, Yao QY, Rickinson AB, Young LS.
    J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS.
    J Exp Med; 1993 Feb 01; 177(2):339-49. PubMed ID: 8381153
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G.
    J Gen Virol; 1989 Nov 01; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [Abstract] [Full Text] [Related]

  • 7. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.
    Brink AA, Vervoort MB, Middeldorp JM, Meijer CJ, van den Brule AJ.
    J Clin Microbiol; 1998 Nov 01; 36(11):3164-9. PubMed ID: 9774558
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T.
    Br J Cancer; 1996 Aug 01; 74(4):625-31. PubMed ID: 8761381
    [Abstract] [Full Text] [Related]

  • 9. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun 01; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 10. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
    Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB.
    J Virol; 1992 Jan 01; 66(1):122-31. PubMed ID: 1309242
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Fåhraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P.
    Int J Cancer; 1988 Sep 15; 42(3):329-38. PubMed ID: 2843473
    [Abstract] [Full Text] [Related]

  • 13. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I.
    Gan To Kagaku Ryoho; 2000 May 15; 27 Suppl 2():248-60. PubMed ID: 10895161
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.
    Taylor KA, Wetzel S, Lyles DS, Pollok BA.
    J Virol; 1994 Oct 15; 68(10):6421-31. PubMed ID: 8083980
    [Abstract] [Full Text] [Related]

  • 16. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB.
    Virology; 1992 Mar 15; 187(1):189-201. PubMed ID: 1310556
    [Abstract] [Full Text] [Related]

  • 17. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
    Busson P, McCoy R, Sadler R, Gilligan K, Tursz T, Raab-Traub N.
    J Virol; 1992 May 15; 66(5):3257-62. PubMed ID: 1313931
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS.
    Blood; 1995 Jul 15; 86(2):659-65. PubMed ID: 7605996
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May 15; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
    Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E.
    Blood; 1997 Aug 01; 90(3):1186-91. PubMed ID: 9242551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.